An effective approach to modulate mitochondrial function in murine primary macrophages by a mitochondria-targeted nanocapsule, MITO-Porter
Mitsue Hibino(Hokkaido University), Misa Hirose(University Hospital Schleswig-Holstein), Emilio Porcu(University of Göttingen), Kerstin Lüdtke‐Buzug(Fraunhofer-Einrichtung für Individualisierte Medizintechnik), Yuma Yamada(Hokkaido University), Libia Lara Carrion(Khalifa University of Science and Technology), Tobia Filosi(University of Trento), Ankit Malhotra(Fraunhofer-Einrichtung für Individualisierte Medizintechnik), Saleh Ibrahim(Khalifa University of Science and Technology)
Cited by 10
Related Papers
Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases
|Advanced Drug Delivery Reviews|2008|254
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
|Advanced Drug Delivery Reviews|2020|123
Challenges in Promoting Mitochondrial Transplantation Therapy
|International Journal of Molecular Sciences|2020|106
Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver
|Journal of Controlled Release|2015|97
mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis
|PLoS ONE|2008|73